skip to main
|
skip to sidebar
Friday, December 25, 2015
Top nephrology-related stories of 2015
›
What a year 2015 turned out to be. Nephrology social media is beginning to mature with many projects adding to a rich educational experi...
3 comments:
Thursday, December 17, 2015
Stop-IgA: Immunosuppression for proteinuric IgA Nephropathy
›
Despite being the world’s most common form of glomerulonephritis, IgA Nephropathy treatment strategies have hereto been controversial, par...
3 comments:
Donor smoking and recipient outcomes in kidney transplantation
›
I evaluated a young kidney donor candidate in clinic a few days ago and although he did not have any obvious medical issues and was an exc...
Friday, December 11, 2015
Lazarus Kidney
›
For my inaugural RFN post, a special case I saw last year with Dr. David Mount and Young-Soo Song a fellow nephrologist in training at BMC. ...
Thursday, December 10, 2015
Renal Pathology Series from WashU
›
Check out the excellent renal clinico-pathology conference series from Tim Yau from the Washington University in St. Louis Division of Nephr...
2 comments:
Wednesday, December 9, 2015
Pharmacokinetic Alterations in the Elderly; You’re Not Too Young to Understand
›
Renal transplantation reduces mortality in elderly patients by more than 50%, however, challenges are magnified in elderly renal transplant...
Sunday, December 6, 2015
Targeting Uric Acid in CKD
›
In our search for therapies to reduce CKD progression, hyperuricemia has historically not been a major target despite being a potential ri...
1 comment:
Friday, December 4, 2015
Top Nephrology '15 Contender: Treating Hepatitis C Infection in CKD: Results of the Surfer-C Study
›
Hepatitis C infection is a major public health issue, affecting approximately 2.8% of the world’s population (>185 million people worl...
Wednesday, November 18, 2015
What does SPRINT mean for HTN and CKD?
›
There has been much fanfare regarding the release of the SPRINT trial in the last several weeks. Finally, evidence that intensive blood pr...
2 comments:
‹
›
Home
View web version